Biological
Amilomotide clinical trials
Also written CAD106.
- studies test it
- 7
- open now
- 0
- in phase 3
- 1
- first study started
- 2005
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
7 studies that test it; most in 2008 (2)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 6
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 7 · Other 0
Often tested with
Tested in the same studies.
Aluminum sulfate (1) · Aluminium sulfate (1) · MF59 (1) · Umibecestat (1)
Studies
Open first, then newest update. How each study uses amilomotide is read from its arms, and is right about nine times in ten.
Testing it · 7
- A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseTerminatedPhase 2/3Novartis PharmaceuticalsNCT02565511Written as CAD106 Immunotherapy
- Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer PatientsCompletedPhase 2Novartis PharmaceuticalsNCT01097096Written as CAD106
- Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's PatientsCompletedPhase 2NovartisNCT00795418Written as CAD106
- To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's PatientsCompletedPhase 2NovartisNCT01023685Written as CAD106
- Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.CompletedPhase 2NovartisNCT00733863Written as CAD106
- To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's PatientsCompletedPhase 2NovartisNCT00956410Written as CAD106
- Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD)CompletedPhase 1Novartis PharmaceuticalsNCT00411580Written as CAD106
Codes
What other systems call amilomotide · ClinicalTrials.gg INT014568
- UNII (FDA) 31830Y299XAMILOMOTIDEOne source FDA
- NCI Thesaurus C166623AmilomotideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 31830Y299X | AMILOMOTIDE | One source FDA |
| NCI Thesaurus | C166623 | Amilomotide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.